Abstract |
Reduced derivatives of 10-formylfolate have been evaluated as inhibitors of mammalian thymidylate synthase (EC 2.1.1.45) from H35 hepatoma cells. With 5,10-methylenetetrahydrofolylheptaglutamate as the substrate, 10-formyltetrahydrofolylmonoglutamate is a competitive inhibitor with a Ki of 2.4 microM, which is reduced to 0.1 microM for the heptaglutamate derivative. 10-Formyldihydrofolylmono- and -heptaglutamate are approximately threefold less inhibitory than the tetrahydro analog. The concentrations of 10-formyltetrahydrofolate and 10-formyldihydrofolate were measured in dividing hepatoma cells by a novel enzymatic assay and were found to be 5 microM and undetectable, respectively. These results suggest that the concentration of 10-formyltetrahydrofolate within the dividing cells has the potential to severely inhibit or modulate thymidylate biosynthesis.
|
Authors | M Balinska, M Rhee, J M Whiteley, D G Priest, J Galivan |
Journal | Archives of biochemistry and biophysics
(Arch Biochem Biophys)
Vol. 284
Issue 1
Pg. 219-22
(Jan 1991)
ISSN: 0003-9861 [Print] United States |
PMID | 1989499
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Formyltetrahydrofolates
- Glutamates
- 10-formyltetrahydropteroylglutamic acid
- Thymidylate Synthase
- Leucovorin
|
Topics |
- Animals
- Binding, Competitive
- Formyltetrahydrofolates
(pharmacology)
- Glutamates
(pharmacology)
- In Vitro Techniques
- Kinetics
- Leucovorin
(analogs & derivatives, metabolism)
- Liver Neoplasms, Experimental
(enzymology)
- Thymidylate Synthase
(antagonists & inhibitors)
- Tumor Cells, Cultured
|